Zobrazeno 1 - 10
of 33
pro vyhledávání: '"J. P. Michiel Sedelaar"'
Autor:
Diederik J. H. Baas, Jan Reitsma, Lieke van Gerwen, Jaron Vleghaar, Jolanda M. L. G. Gehlen, Cathelijne M. P. Ziedses des Plantes, Jean Paul A. van Basten, Roderick C. N. van den Bergh, H. Max Bruins, Eelco R. P. Collette, Robert J. Hoekstra, Ben C. Knipscheer, Pim J. van Leeuwen, Daphne Luijendijk-de Bruin, Joep G. H. van Roermund, J. P. Michiel Sedelaar, Tommy G. W. Speel, Saskia P. Stomps, Carl J. Wijburg, Rob P. W. F. Wijn, Igle Jan de Jong, Diederik M. Somford
Publikováno v:
Cancers, Vol 15, Iss 24, p 5740 (2023)
The use of healthcare insurance claims data for urinary incontinence (UI) pads has the potential to serve as an objective measure for assessing post-radical prostatectomy UI rates, but its validity for this purpose has not been established. The aim o
Externí odkaz:
https://doaj.org/article/86e0d2b13add44edb2198fac41953de6
Autor:
Ingeborg van den Berg, Timo F. W. Soeterik, Erik J. R. J. van der Hoeven, Bart Claassen, Wyger M. Brink, Diederik J. H. Baas, J. P. Michiel Sedelaar, Lizette Heine, Jim Tol, Jochem R. N. van der Voort van Zyp, Cornelis A. T. van den Berg, Roderick C. N. van den Bergh, Jean-Paul A. van Basten, Harm H. E. van Melick
Publikováno v:
Cancers, Vol 15, Iss 22, p 5452 (2023)
Adequate detection of the histopathological extraprostatic extension (EPE) of prostate cancer (PCa) remains a challenge using conventional radiomics on 3 Tesla multiparametric magnetic resonance imaging (3T mpMRI). This study focuses on the assessmen
Externí odkaz:
https://doaj.org/article/679da5e06d6d4af4befb4c195dc2d228
Autor:
Yvonne Wimper, Christiaan G. Overduin, J. P. Michiel Sedelaar, Jeroen Veltman, Sjoerd F. M. Jenniskens, Joyce G. R. Bomers, Jurgen J. Fütterer
Publikováno v:
Cancers, Vol 15, Iss 16, p 4093 (2023)
Patients with localized recurrent prostate cancer (PCa) are eligible for androgen-deprivation therapy, salvage radical prostatectomy (RP) or radiation therapy. These treatments are associated with serious side-effects, illustrating the need for alter
Externí odkaz:
https://doaj.org/article/f9f65a9ae1614a9daed05bdf83833f5c
Autor:
Maria V. Luna‐Velez, Jelmer J. Dijkstra, Marina A. Heuschkel, Frank P. Smit, Guillaume van de Zande, Dominique Smeets, J. P. Michiel Sedelaar, Michiel Vermeulen, Gerald W. Verhaegh, Jack A. Schalken
Publikováno v:
Molecular Oncology, Vol 15, Iss 7, Pp 1882-1900 (2021)
Bladder urothelial cell carcinoma (UCC) incidence is about three times higher in men compared with women. There are several indications for the involvement of hormonal factors in the aetiology of UCC. Here, we provide evidence of androgen signalling
Externí odkaz:
https://doaj.org/article/232b1f170c384ea19e66163c0f81904f
Autor:
Sofie C. M. Tops, Evert L. Koldewijn, Diederik M. Somford, Anita M. P. Huis, Eva Kolwijck, Heiman F. L. Wertheim, Marlies E. J. L. Hulscher, J. P. Michiel Sedelaar
Publikováno v:
BMC Urology, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background The clinical landscape of prostate biopsy (PB) is evolving with changes in procedures and techniques. Moreover, antibiotic resistance is increasing and influences the efficacy of pre-biopsy prophylactic regimens. Therefore, increa
Externí odkaz:
https://doaj.org/article/a975e9c10fc04995b102ad107775131a
Autor:
Amina Banda, Bastiaan M. Privé, Youssra Allach, Maike J. M. Uijen, Steffie M. B. Peters, Cato C. Loeff, Martin Gotthardt, Constantijn H. J. Muselaers, J. Alfred Witjes, Inge M. van Oort, J. P. Michiel Sedelaar, Harm Westdorp, Niven Mehra, Fadi Khreish, Samer Ezziddin, Amir Sabet, Michael C. Kreissl, Thomas Winkens, Philipp Seifert, Marcel J. R. Janssen, Willemijn A. M. van Gemert, James Nagarajah
Publikováno v:
Cancers, Vol 15, Iss 1, p 297 (2022)
Background: Prostate-specific membrane antigen (PSMA)-directed radioligand therapy (RLT) is a novel treatment for patients with castration-resistant prostate cancer (CRPC). Given the mode of action, patients in an earlier disease stage, such as hormo
Externí odkaz:
https://doaj.org/article/5c35f622f03042f68943dcaaa9d10c40
Autor:
Jeroen H. A. Creemers, Maarten J. van der Doelen, Sandra van Wilpe, Rick Hermsen, Tjitske Duiveman-de Boer, Diederik M. Somford, Marcel J. R. Janssen, J. P. Michiel Sedelaar, Niven Mehra, Johannes Textor, Harm Westdorp
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundRadium-223 improves overall survival (OS) in men with bone metastatic castration-resistant prostate cancer (mCRPC). While the exact mechanism behind this survival benefit remains unclear, radium-induced immunological mechanisms might contri
Externí odkaz:
https://doaj.org/article/9681b271f3804ad081b66ebff52e0e79
Autor:
Anouk Anna Maria Arnoldus van der Aa, Christophe Koenraad Mannaerts, Maudy C. W. Gayet, Johannes Cornelis van der Linden, Barthold Philip Schrier, J. P. Michiel Sedelaar, Massimo Mischi, Harrie P. Beerlage, Hessel Wijkstra
Publikováno v:
BMC Urology, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background To overcome the limitations regarding two dimensional (2D) greyscale (GS) transrectal ultrasound (TRUS)-guided biopsy in prostate cancer (PCa) detection and tissue packaging in biopsy processing, there is an ongoing focus on new i
Externí odkaz:
https://doaj.org/article/0fc7dbd4164c4fe0bcb9c30208d0e9f7
Autor:
Lejla Kočo, Harm H. A. Weekenstroo, Doenja M. J. Lambregts, J. P. Michiel Sedelaar, Mathias Prokop, Jurgen J. Fütterer, Ritse M. Mann
Publikováno v:
Cancers, Vol 13, Iss 16, p 4159 (2021)
Objective: The aim of our systematic review is to identify the effects of multidisciplinary team meetings (MDTM) for lung, breast, colorectal and prostate cancer. Methods: Our systematic review, performed following PRISMA guidelines, included studies
Externí odkaz:
https://doaj.org/article/b9ec46d4ceed47a99024de3f1fbba6bd
Autor:
Peter F. A. Mulders, Jack A. Schalken, Jelle O. Barentsz, J. P. Michiel Sedelaar, Jurgen J. Futterer, Inge M. van Oort, Elisabeth A. Wierenga, Gisele H. J. M. Leyten
Publikováno v:
International Journal of Molecular Sciences, Vol 14, Iss 6, Pp 11347-11355 (2013)
PCA3 (prostate cancer gene 3) and multiparametric 3 tesla MRI are new promising diagnostic tools in the detection of PCa. Our aim was to study the clinical value of the Progensa PCA3-test: its predictive value for biopsy outcome, Gleason score and MR
Externí odkaz:
https://doaj.org/article/b518b6ebc8da46a39b6b0489afa2220e